Avecia is a leading private biotechnology company focused on the development and manufacture of innovative biotechnology-based medicines. With a long history of technological innovation, we work closely with our customers - who are typically biotechnology or pharmaceutical companies - helping them achieve fast progress into, and through, the clinical development programme.

We have two main operating business units:



In addition our headquarters operation is located in Manchester, UK.

Whilst the two business units operate independently, the enthusiasm, knowledge and skills of our people are common across both, enabling our customers to realise the potential of their exciting new medical treatments for serious diseases such as cancer and heart disease.